Home › Urothelial (Transitional Cell) Carcinoma › Idaho › Boise
Urothelial (Transitional Cell) Carcinoma clinical trials in Boise, ID
3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Boise (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- St. Luke's Cancer Institute: Boise, Boise
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Boise
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Austin, TX10 studies
Other studies in Boise
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Colon Cancer7 studies
- Colorectal Cancer6 studies
- Respiratory Distress Syndrome6 studies
- Breast Cancer6 studies
- Melanoma6 studies
- Burkitt Lymphoma5 studies
- Pancreatic Cancer4 studies
- Myeloproliferative Neoplasms4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.